{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T22:41:32Z","timestamp":1792708892334,"version":"4.5.0"},"reference-count":78,"publisher":"Elsevier BV","issue":"7-8","license":[{"start":{"date-parts":[[2011,6,1]],"date-time":"2011-06-01T00:00:00Z","timestamp":1306886400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2011,6,1]],"date-time":"2011-06-01T00:00:00Z","timestamp":1306886400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2011,6,1]],"date-time":"2011-06-01T00:00:00Z","timestamp":1306886400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2011,6,1]],"date-time":"2011-06-01T00:00:00Z","timestamp":1306886400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2011,6,1]],"date-time":"2011-06-01T00:00:00Z","timestamp":1306886400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2011,6,1]],"date-time":"2011-06-01T00:00:00Z","timestamp":1306886400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuropharmacology"],"published-print":{"date-parts":[[2011,6]]},"DOI":"10.1016\/j.neuropharm.2011.02.021","type":"journal-article","created":{"date-parts":[[2011,3,7]],"date-time":"2011-03-07T19:05:20Z","timestamp":1299524720000},"page":"1355-1363","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":36,"title":["Induced pluripotent stem cells: A new tool to confront the challenge of neuropsychiatric disorders"],"prefix":"10.1016","volume":"60","author":[{"given":"Flora M.","family":"Vaccarino","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanna E.","family":"Stevens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arif","family":"Kocabas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dean","family":"Palejev","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Szekely","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena L.","family":"Grigorenko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sherman","family":"Weissman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.neuropharm.2011.02.021_bib1","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1038\/nature08310","article-title":"Adult mice generated from induced pluripotent stem cells","volume":"461","author":"Boland","year":"2009","journal-title":"Nature"},{"key":"10.1016\/j.neuropharm.2011.02.021_bib2","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1634\/stemcells.2008-0734","article-title":"The role of Lmx1a in the differentiation of human embryonic stem cells into midbrain dopamine neurons in culture and after transplantation into a Parkinson\u2019s disease model","volume":"27","author":"Cai","year":"2009","journal-title":"Stem Cells"},{"key":"10.1016\/j.neuropharm.2011.02.021_bib3","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.1176\/appi.ajp.159.7.1080","article-title":"Obstetric complications and schizophrenia: historical and meta-analytic review","volume":"159","author":"Cannon","year":"2002","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.neuropharm.2011.02.021_bib4","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1073\/pnas.0811426106","article-title":"Reprogramming of murine and human somatic cells using a single polycistronic vector","volume":"106","author":"Carey","year":"2009","journal-title":"Proc. Natl. Acad. Sci. U S A"},{"key":"10.1016\/j.neuropharm.2011.02.021_bib5","doi-asserted-by":"crossref","first-page":"1740","DOI":"10.1001\/jama.288.14.1740","article-title":"Developmental trajectories of brain volume abnormalities in children and adolescents with attention-deficit\/hyperactivity disorder","volume":"288","author":"Castellanos","year":"2002","journal-title":"J.\u00a0Am. Med. Assoc."},{"key":"10.1016\/j.neuropharm.2011.02.021_bib6","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1038\/nbt.1529","article-title":"Highly efficient neural conversion of human ES and iPS cells by dual inhibition of SMAD signaling","volume":"27","author":"Chambers","year":"2009","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.neuropharm.2011.02.021_bib7","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1089\/cell.2010.0019","article-title":"Reprogramming huntington monkey skin cells into pluripotent stem cells","volume":"12","author":"Chan","year":"2010","journal-title":"Cell Reprogram"},{"key":"10.1016\/j.neuropharm.2011.02.021_bib8","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.stem.2009.06.008","article-title":"Induced pluripotent stem cells and embryonic stem cells are distinguished by gene expression signatures","volume":"5","author":"Chin","year":"2009","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.neuropharm.2011.02.021_bib9","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1016\/j.biopsych.2008.01.009","article-title":"Novel submicroscopic chromosomal abnormalities detected in autism spectrum disorder","volume":"63","author":"Christian","year":"2008","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.neuropharm.2011.02.021_bib10","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/j.molcel.2006.04.017","article-title":"Transcription impairment and cell migration defects in elongator-depleted cells: implication for familial dysautonomia","volume":"22","author":"Close","year":"2006","journal-title":"Mol. Cell."},{"key":"10.1016\/j.neuropharm.2011.02.021_bib11","article-title":"Neural differentiation of human ES cells","author":"Cohen","year":"2007","journal-title":"Curr. Protoc. Cell. Biol."},{"key":"10.1016\/j.neuropharm.2011.02.021_bib12","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1038\/nature08516","article-title":"Origins and functional impact of copy number variation in the human genome","volume":"464","author":"Conrad","year":"2010","journal-title":"Nature"},{"key":"10.1016\/j.neuropharm.2011.02.021_bib13","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1038\/nature08248","article-title":"L1 retrotransposition in human neural progenitor cells","volume":"460","author":"Coufal","year":"2009","journal-title":"Nature"},{"key":"10.1016\/j.neuropharm.2011.02.021_bib14","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.1126\/science.1158799","article-title":"Induced pluripotent stem cells generated from patients with ALS can be differentiated into motor neurons","volume":"321","author":"Dimos","year":"2008","journal-title":"Science"},{"key":"10.1016\/j.neuropharm.2011.02.021_bib15","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1038\/nature09534","article-title":"A\u00a0map of human genome variation from population-scale sequencing","volume":"467","author":"Durbin","year":"2010","journal-title":"Nature"},{"key":"10.1016\/j.neuropharm.2011.02.021_bib16","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1038\/nature07677","article-title":"Induced pluripotent stem cells from a spinal muscular atrophy patient","volume":"457","author":"Ebert","year":"2009","journal-title":"Nature"},{"key":"10.1016\/j.neuropharm.2011.02.021_bib17","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1016\/j.stem.2008.09.002","article-title":"Self-organized formation of polarized cortical tissues from ESCs and its active manipulation by extrinsic signals","volume":"3","author":"Eiraku","year":"2008","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.neuropharm.2011.02.021_bib18","article-title":"Human ESC-derived neural rosettes and neural stem cell progression","author":"Elkabetz","year":"2009","journal-title":"Cold Spring Harb. Symp. Quant. Biol"},{"key":"10.1016\/j.neuropharm.2011.02.021_bib19","doi-asserted-by":"crossref","first-page":"348","DOI":"10.2183\/pjab.85.348","article-title":"Efficient induction of transgene-free human pluripotent stem cells using a vector based on Sendai virus, an RNA virus that does not integrate into the host genome","volume":"85","author":"Fusaki","year":"2009","journal-title":"Proc. Jpn. Acad. Ser. B. Phys. Biol. Sci."},{"key":"10.1016\/j.neuropharm.2011.02.021_bib20","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1038\/nature07287","article-title":"An intrinsic mechanism of corticogenesis from embryonic stem cells","volume":"455","author":"Gaspard","year":"2008","journal-title":"Nature"},{"key":"10.1016\/j.neuropharm.2011.02.021_bib21","doi-asserted-by":"crossref","first-page":"2491","DOI":"10.4161\/cc.8.16.9276","article-title":"Making cortex in a dish: in vitro corticopoiesis from embryonic stem cells","volume":"8","author":"Gaspard","year":"2009","journal-title":"Cell Cycle"},{"key":"10.1016\/j.neuropharm.2011.02.021_bib22","doi-asserted-by":"crossref","first-page":"15921","DOI":"10.1073\/pnas.1010209107","article-title":"Differentiated Parkinson patient-derived induced pluripotent stem cells grow in the adult rodent brain and reduce motor asymmetry in Parkinsonian rats","volume":"107","author":"Hargus","year":"2010","journal-title":"Proc. Natl. Acad. Sci. U S A"},{"key":"10.1016\/j.neuropharm.2011.02.021_bib24","doi-asserted-by":"crossref","first-page":"4335","DOI":"10.1073\/pnas.0910012107","article-title":"Neural differentiation of human induced pluripotent stem cells follows developmental principles but with variable potency","volume":"107","author":"Hu","year":"2010","journal-title":"Proc. Natl. Acad. Sci. U S A"},{"key":"10.1016\/j.neuropharm.2011.02.021_bib25","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/j.tig.2008.03.001","article-title":"The functional impact of structural variation in humans","volume":"24","author":"Hurles","year":"2008","journal-title":"Trends Genet."},{"key":"10.1016\/j.neuropharm.2011.02.021_bib26","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1126\/science.1085649","article-title":"Hirschsprung disease is linked to defects in neural crest stem cell function","volume":"301","author":"Iwashita","year":"2003","journal-title":"Science"},{"key":"10.1016\/j.neuropharm.2011.02.021_bib27","doi-asserted-by":"crossref","first-page":"3069","DOI":"10.1523\/JNEUROSCI.4562-06.2007","article-title":"Functional neural development from human embryonic stem cells: accelerated synaptic activity via astrocyte coculture","volume":"27","author":"Johnson","year":"2007","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.neuropharm.2011.02.021_bib28","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1016\/j.neuron.2009.03.027","article-title":"Functional and evolutionary insights into human brain development through global transcriptome analysis","volume":"62","author":"Johnson","year":"2009","journal-title":"Neuron"},{"key":"10.1016\/j.neuropharm.2011.02.021_bib29","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1038\/nature07864","article-title":"Virus-free induction of pluripotency and subsequent excision of reprogramming factors","volume":"458","author":"Kaji","year":"2009","journal-title":"Nature"},{"key":"10.1016\/j.neuropharm.2011.02.021_bib30","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1002\/stem.31","article-title":"Directed differentiation of human-induced pluripotent stem cells generates active motor neurons","volume":"27","author":"Karumbayaram","year":"2009","journal-title":"Stem Cells"},{"key":"10.1016\/j.neuropharm.2011.02.021_bib31","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1002\/cne.22206","article-title":"Decreased number of parvalbumin and cholinergic interneurons in the striatum of individuals with Tourette syndrome","volume":"518","author":"Kataoka","year":"2010","journal-title":"J.\u00a0Comp. Neurol."},{"key":"10.1016\/j.neuropharm.2011.02.021_bib34","doi-asserted-by":"crossref","first-page":"1865","DOI":"10.1101\/gr.081422.108","article-title":"Analysis of copy number variants and segmental duplications in the human genome: evidence for a change in the process of formation in recent evolutionary history","volume":"18","author":"Kim","year":"2008","journal-title":"Genome Res."},{"key":"10.1016\/j.neuropharm.2011.02.021_bib32","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1016\/j.stem.2009.05.005","article-title":"Generation of human induced pluripotent stem cells by direct delivery of reprogramming proteins","volume":"4","author":"Kim","year":"2009","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.neuropharm.2011.02.021_bib33","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1038\/nature09342","article-title":"Epigenetic memory in induced pluripotent stem cells","volume":"467","author":"Kim","year":"2010","journal-title":"Nature"},{"key":"10.1016\/j.neuropharm.2011.02.021_bib35","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1126\/science.1149504","article-title":"Paired-end mapping reveals extensive structural variation in the human genome","volume":"318","author":"Korbel","year":"2007","journal-title":"Science"},{"key":"10.1016\/j.neuropharm.2011.02.021_bib36","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1038\/nature08320","article-title":"Modelling pathogenesis and treatment of familial dysautonomia using patient-specific iPSCs","volume":"461","author":"Lee","year":"2009","journal-title":"Nature"},{"key":"10.1016\/j.neuropharm.2011.02.021_bib37","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pbio.0050254","article-title":"The diploid genome sequence of an individual human","volume":"5","author":"Levy","year":"2007","journal-title":"PLoS Biol"},{"key":"10.1016\/j.neuropharm.2011.02.021_bib38","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1038\/nbt1063","article-title":"Specification of motoneurons from human embryonic stem cells","volume":"23","author":"Li","year":"2005","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.neuropharm.2011.02.021_bib39","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1038\/nature08494","article-title":"Finding the missing heritability of complex diseases","volume":"461","author":"Manolio","year":"2009","journal-title":"Nature"},{"key":"10.1016\/j.neuropharm.2011.02.021_bib40","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/j.cell.2010.10.016","article-title":"A\u00a0model for neural development and treatment of rett syndrome using human induced pluripotent stem cells","volume":"143","author":"Marchetto","year":"2010","journal-title":"Cell"},{"key":"10.1016\/j.neuropharm.2011.02.021_bib41","doi-asserted-by":"crossref","first-page":"1166","DOI":"10.1038\/ng.238","article-title":"Integrated detection and population-genetic analysis of SNPs and copy number variation","volume":"40","author":"McCarroll","year":"2008","journal-title":"Nat. Genet."},{"key":"10.1016\/j.neuropharm.2011.02.021_bib42","doi-asserted-by":"crossref","first-page":"1841","DOI":"10.1113\/jphysiol.2010.188482","article-title":"Sodium channel gene family: epilepsy mutations, gene interactions and modifier effects","volume":"588","author":"Meisler","year":"2010","journal-title":"J.\u00a0Physiol."},{"key":"10.1016\/j.neuropharm.2011.02.021_bib43","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1038\/nbt1335","article-title":"Direct reprogramming of genetically unmodified fibroblasts into pluripotent stem cells","volume":"25","author":"Meissner","year":"2007","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.neuropharm.2011.02.021_bib44","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1038\/nature06008","article-title":"Genome-wide maps of chromatin state in pluripotent and lineage-committed cells","volume":"448","author":"Mikkelsen","year":"2007","journal-title":"Nature"},{"key":"10.1016\/j.neuropharm.2011.02.021_bib45","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1038\/nature09708","article-title":"Mapping copy number variation by population-scale genome sequencing","volume":"470","author":"Mills","year":"2011","journal-title":"Nature"},{"key":"10.1016\/j.neuropharm.2011.02.021_bib46","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1038\/nature09544","article-title":"L1 retrotransposition in neurons is modulated by MeCP2","volume":"468","author":"Muotri","year":"2010","journal-title":"Nature"},{"key":"10.1016\/j.neuropharm.2011.02.021_bib47","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1016\/j.neuropharm.2010.01.019","article-title":"Recent advancements in stem cell and gene therapies for neurological disorders and intractable epilepsy","volume":"58","author":"Naegele","year":"2010","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2011.02.021_bib48","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1126\/science.1164270","article-title":"Generation of mouse induced pluripotent stem cells without viral vectors","volume":"322","author":"Okita","year":"2008","journal-title":"Science"},{"key":"10.1016\/j.neuropharm.2011.02.021_bib49","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1038\/nbt1383","article-title":"Marked differences in differentiation propensity among human embryonic stem cell lines","volume":"26","author":"Osafune","year":"2008","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.neuropharm.2011.02.021_bib50","doi-asserted-by":"crossref","first-page":"1511","DOI":"10.1634\/stemcells.2006-0707","article-title":"Directed neural differentiation of human embryonic stem cells via an obligated primitive anterior stage","volume":"25","author":"Pankratz","year":"2007","journal-title":"Stem Cells"},{"key":"10.1016\/j.neuropharm.2011.02.021_bib51","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1038\/ng.555","article-title":"Discovery of common Asian copy number variants using integrated high-resolution array CGH and massively parallel DNA sequencing","volume":"42","author":"Park","year":"2010","journal-title":"Nat. Genet."},{"key":"10.1016\/j.neuropharm.2011.02.021_bib52","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1016\/j.cell.2008.07.041","article-title":"Disease-specific induced pluripotent stem cells","volume":"134","author":"Park","year":"2008","journal-title":"Cell"},{"key":"10.1016\/j.neuropharm.2011.02.021_bib53","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1001\/archpsyc.58.5.427","article-title":"Regional brain and ventricular volumes in Tourette syndrome","volume":"58","author":"Peterson","year":"2001","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.neuropharm.2011.02.021_bib54","doi-asserted-by":"crossref","first-page":"6273","DOI":"10.1073\/pnas.0805311106","article-title":"Cortical thinning in persons at increased familial risk for major depression","volume":"106","author":"Peterson","year":"2009","journal-title":"Proc. Natl. Acad. Sci. U S A"},{"key":"10.1016\/j.neuropharm.2011.02.021_bib55","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1038\/nbt.1667","article-title":"Cell type of origin influences the molecular and functional properties of mouse induced pluripotent stem cells","volume":"28","author":"Polo","year":"2010","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.neuropharm.2011.02.021_bib56","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1016\/S0006-3223(99)00041-4","article-title":"Morphometric evidence for neuronal and glial prefrontal cell pathology in major depression","volume":"45","author":"Rajkowska","year":"1999","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.neuropharm.2011.02.021_bib57","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/0166-2236(95)93934-P","article-title":"A\u00a0small step for the cell, a giant leap for mankind: a hypothesis of neocortical expansion during evolution","volume":"18","author":"Rakic","year":"1995","journal-title":"Trends Neurosci."},{"key":"10.1016\/j.neuropharm.2011.02.021_bib58","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1016\/j.stem.2009.11.009","article-title":"Technical challenges in using human induced pluripotent stem cells to model disease","volume":"5","author":"Saha","year":"2009","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.neuropharm.2011.02.021_bib59","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1126\/science.1138659","article-title":"Strong association of de novo copy number mutations with autism","volume":"316","author":"Sebat","year":"2007","journal-title":"Science"},{"key":"10.1016\/j.neuropharm.2011.02.021_bib60","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1007\/s12015-010-9121-x","article-title":"Progress and promise towards safe induced pluripotent stem cells for therapy","volume":"6","author":"Seifinejad","year":"2010","journal-title":"Stem Cell Rev."},{"key":"10.1016\/j.neuropharm.2011.02.021_bib61","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.stem.2010.06.003","article-title":"Generation of induced pluripotent stem cells from human terminally differentiated circulating T cells","volume":"7","author":"Seki","year":"2010","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.neuropharm.2011.02.021_bib62","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1186\/1471-213X-10-81","article-title":"Generation of human induced pluripotent stem cells by simple transient transfection of plasmid DNA encoding reprogramming factors","volume":"10","author":"Si-Tayeb","year":"2010","journal-title":"BMC Dev. Biol."},{"key":"10.1016\/j.neuropharm.2011.02.021_bib63","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1093\/hmg\/ddh046","article-title":"Rescue of a human mRNA splicing defect by the plant cytokinin kinetin","volume":"13","author":"Slaugenhaupt","year":"2004","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.neuropharm.2011.02.021_bib64","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1016\/j.cell.2009.02.013","article-title":"Parkinson\u2019s disease patient-derived induced pluripotent stem cells free of viral reprogramming factors","volume":"136","author":"Soldner","year":"2009","journal-title":"Cell"},{"key":"10.1016\/j.neuropharm.2011.02.021_bib65","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1038\/nature07229","article-title":"Large recurrent microdeletions associated with schizophrenia","volume":"455","author":"Stefansson","year":"2008","journal-title":"Nature"},{"key":"10.1016\/j.neuropharm.2011.02.021_bib66","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1016\/j.cell.2007.11.019","article-title":"Induction of pluripotent stem cells from adult human fibroblasts by defined factors","volume":"131","author":"Takahashi","year":"2007","journal-title":"Cell"},{"key":"10.1016\/j.neuropharm.2011.02.021_bib67","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1038\/npp.2009.115","article-title":"Normal development of brain circuits","volume":"35","author":"Tau","year":"2010","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neuropharm.2011.02.021_bib68","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1126\/science.282.5391.1145","article-title":"Embryonic stem cell lines derived from human blastocysts","volume":"282","author":"Thomson","year":"1998","journal-title":"Science"},{"key":"10.1016\/j.neuropharm.2011.02.021_bib69","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/j.stem.2010.04.005","article-title":"Differential modeling of fragile X syndrome by human embryonic stem cells and induced pluripotent stem cells","volume":"6","author":"Urbach","year":"2010","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.neuropharm.2011.02.021_bib70","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1016\/j.stem.2010.08.012","article-title":"Highly efficient reprogramming to pluripotency and directed differentiation of human cells with synthetic modified mRNA","volume":"7","author":"Warren","year":"2010","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.neuropharm.2011.02.021_bib71","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1056\/NEJMoa075974","article-title":"Association between microdeletion and microduplication at 16p11.2 and autism","volume":"358","author":"Weiss","year":"2008","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.neuropharm.2011.02.021_bib72","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1038\/nature05944","article-title":"In vitro reprogramming of fibroblasts into a pluripotent ES-cell-like state","volume":"448","author":"Wernig","year":"2007","journal-title":"Nature"},{"key":"10.1016\/j.neuropharm.2011.02.021_bib73","doi-asserted-by":"crossref","first-page":"5856","DOI":"10.1073\/pnas.0801677105","article-title":"Neurons derived from reprogrammed fibroblasts functionally integrate into the fetal brain and improve symptoms of rats with Parkinson\u2019s disease","volume":"105","author":"Wernig","year":"2008","journal-title":"Proc. Natl. Acad. Sci. U S A"},{"key":"10.1016\/j.neuropharm.2011.02.021_bib74","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1038\/nature07863","article-title":"piggyBac transposition reprograms fibroblasts to induced pluripotent stem cells","volume":"458","author":"Woltjen","year":"2009","journal-title":"Nature"},{"key":"10.1016\/j.neuropharm.2011.02.021_bib75","doi-asserted-by":"crossref","first-page":"1917","DOI":"10.1126\/science.1151526","article-title":"Induced pluripotent stem cell lines derived from human somatic cells","volume":"318","author":"Yu","year":"2007","journal-title":"Science"},{"key":"10.1016\/j.neuropharm.2011.02.021_bib76","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1126\/science.1172482","article-title":"Human induced pluripotent stem cells free of vector and transgene sequences","volume":"324","author":"Yu","year":"2009","journal-title":"Science"},{"key":"10.1016\/j.neuropharm.2011.02.021_bib77","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1038\/nature08267","article-title":"iPS cells produce viable mice through tetraploid complementation","volume":"461","author":"Zhao","year":"2009","journal-title":"Nature"},{"key":"10.1016\/j.neuropharm.2011.02.021_bib79","doi-asserted-by":"crossref","first-page":"2667","DOI":"10.1002\/stem.201","article-title":"Adenoviral gene delivery can reprogram human fibroblasts to induced pluripotent stem cells","volume":"27","author":"Zhou","year":"2009","journal-title":"Stem Cells"},{"key":"10.1016\/j.neuropharm.2011.02.021_bib78","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/j.stem.2009.04.005","article-title":"Generation of induced pluripotent stem cells using recombinant proteins","volume":"4","author":"Zhou","year":"2009","journal-title":"Cell Stem Cell"}],"container-title":["Neuropharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390811001018?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390811001018?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,1,23]],"date-time":"2024-01-23T13:53:18Z","timestamp":1706017998000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0028390811001018"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,6]]},"references-count":78,"journal-issue":{"issue":"7-8","published-print":{"date-parts":[[2011,6]]}},"alternative-id":["S0028390811001018"],"URL":"https:\/\/doi.org\/10.1016\/j.neuropharm.2011.02.021","relation":{},"ISSN":["0028-3908"],"issn-type":[{"value":"0028-3908","type":"print"}],"subject":[],"published":{"date-parts":[[2011,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Induced pluripotent stem cells: A new tool to confront the challenge of neuropsychiatric disorders","name":"articletitle","label":"Article Title"},{"value":"Neuropharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neuropharm.2011.02.021","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2011 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}